Abstract: A valerian composition includes valerian and an acidifying agent blended together in a pharmaceutically acceptable hydrogel-forming polymer matrix. An expedited release portion of the dosage form includes 5% to 50% of the valerian and is effective to release the valerian therein within 2 hours from placement in a 0.1 N HCl solution. A sustained release portion of the dosage form includes the remainder of the valerian and is effective to release the valerian therein within 10 hours from placement in a phosphate buffer with a pH of 6.8.

Abstract: A Radio Frequency Identification (RFID) tag IC stores an identifier and a check code. The IC determines whether the stored identifier is corrupted by comparing it to the check code. If the stored identifier does not correspond to the check code then the IC may terminate operation or indicate an error. The IC may also reconstruct the correct identifier from the check code.

Abstract: Disclosed are various embodiments of lipid multiparticulate compositions comprising at least one active agent, a low flow point excipient, and a high flow point excipient.

Abstract: Effervescent self-emulsifying drug delivery system formulations for oral administration of water-insoluble cannabinoids are disclosed.

Abstract: A valerian composition includes valerian and an acidifying agent blended together in a pharmaceutically acceptable hydrogel-forming polymer matrix. An expedited release portion of the dosage form includes 5% to 50% of the valerian and is effective to release the valerian therein within 2 hours from placement in a 0.1 N HCl solution. A sustained release portion of the dosage form includes the remainder of the valerian and is effective to release the valerian therein within 10 hours from placement in a phosphate buffer with a pH of 6.8.

Abstract: A valerian composition includes a therapeutically effective pharmaceutical dosage form having a solid core including a polymer in which valerian and a valerian stability improving amount of an acidifying agent are contained. The valerian stability improving amount of acidifying agent being sufficient to impart a pH of 2 to 5 to the polymer.

Abstract: A valerian composition includes a therapeutically effective pharmaceutical dosage form having a solid core including a polymer in which valerian and a valerian stability improving amount of an acidifying agent are contained. The valerian stability improving amount of acidifying agent being sufficient to impart a pH of 2 to 5 to the polymer.

Abstract: Controlled-release therapeutic compositions including melatonin combined with sedative and/or analgesic ingredients are described. The compositions have a solid core including melatonin in an acidified polymeric matrix. A sedative ingredient such as GABA receptor agonist may also be in the acidified polymeric matrix. The composition may include an expedited release portion providing a burst release of active ingredients and a sustained release portion providing a sustained release of active ingredients.

Abstract: A Radio Frequency Identification (RFID) tag IC stores an identifier and a check code. The IC determines whether the stored identifier is corrupted by comparing it to the check code. If the stored identifier does not correspond to the check code then the IC may terminate operation or indicate an error. The IC may also reconstruct the correct identifier from the check code.

Abstract: Controlled-release therapeutic compositions including melatonin combined with sedative and/or analgesic ingredients are described. The compositions have a solid core including melatonin in an acidified polymeric matrix. A sedative ingredient such as GABA receptor agonist may also be in the acidified polymeric matrix. The composition may include an expedited release portion providing a burst release of active ingredients and a sustained release portion providing a sustained release of active ingredients.

Abstract: A valerian composition includes a therapeutically effective pharmaceutical dosage form having a solid core including a polymer in which valerian and a valerian stability improving amount of an acidifying agent are contained. The valerian stability improving amount of acidifying agent being sufficient to impart a pH of 2 to 5 to the polymer.

Abstract: A valerian composition includes a therapeutically effective pharmaceutical dosage form having a solid core including a polymer in which valerian and a valerian stability improving amount of an acidifying agent are contained. The valerian stability improving amount of acidifying agent being sufficient to impart a pH of 2 to 5 to the polymer.

Abstract: A Radio Frequency Identification (RFID) tag IC stores an identifier and a check code. The IC determines whether the stored identifier is corrupted by comparing it to the check code. If the stored identifier does not correspond to the check code then the IC may terminate operation or indicate an error. The IC may also reconstruct the correct identifier from the check code.

Abstract: A valerian composition includes a therapeutically effective pharmaceutical dosage form having a solid core including a polymer in which valerian and a valerian stability improving amount of an acidifying agent are contained. The valerian stability improving amount of acidifying agent being sufficient to impart a pH of 2 to 5 to the polymer.

Abstract: Formulations for oral administration of water-insoluble cannabinoids are disclosed. More particularly, self-emulsifying drug delivery systems for oral administration of water-insoluble, lipophilic cannabinoids are disclosed.

Abstract: Solid lipid particles comprising a lipid hydrophobic matrix and from about 5 wt. % to about 30 wt. % of curcumin, and methods of making and treatment thereof.

Abstract: Controlled-release therapeutic compositions including melatonin combined with sedative and/or analgesic ingredients are described. The compositions have a solid core including melatonin in an acidified polymeric matrix. A sedative ingredient such as GABA receptor agonist may also be in the acidified polymeric matrix. The composition may include an expedited release portion providing a burst release of active ingredients and a sustained release portion providing a sustained release of active ingredients.

Abstract: A cryptographically-enabled RFID tag stores a primary secret key and derives secondary keys from the primary key. A secondary key may be derived by combining the primary key with one or more other parameters using one or more algorithms. The tag uses a derived secondary key to encrypt or electronically sign a tag response sent to a verifying entity. The verifying entity does not know the derived secondary key, but knows the tag primary key and the parameters and algorithms used to derive the secondary key and can derive all of the potential secondary keys. The verifying entity can then attempt to authenticate the tag or tag response by trying potential secondary keys.

Abstract: Embodiments are directed to sequential encoding for RFID tags. An encoding line transports an RFID tag from the reading zone of a first reader to the reading zone of a second reader. The first reader communicates with the tag, writes a portion of an identifier to the tag, and sends a tag write status to the second reader. The second reader, situated after the first reader, communicates with the tag, receives the tag write status from the first reader, then determines a remaining portion of the identifier to be written to the tag based on the tag write status. The second reader then attempts to write the remaining portion to the tag. If the attempt fails, the second reader initiates an error-handling procedure.

Abstract: An RFID tag tuning circuit may be capable of adjusting the impedance matching between an RFID integrated circuit (IC) and an antenna on an RFID tag to increase the amount of power that the IC can extract from an incident RF wave. The tuning circuit switches a variable impedance coupling the antenna and the IC between several different impedance settings, where each impedance setting differs from an adjacent impedance setting by a respective impedance step size and at least one impedance step size has a different value than another impedance step size. The tuning circuit may switch the variable impedance by incrementing through a counter, decrementing through the counter, or performing some search algorithm. The tuning circuit may also initialize the variable impedance based on a default impedance setting or a random impedance setting derived from a random counter.